Gary Schwartz M.D.

Steimer, D. A., O. Hernandez, D. P. Mason and G. S. Schwartz (2019). “Timing of ECMO Initiation Impacts Survival in Influenza-Associated ARDS.” Thorac Cardiovasc Surg 67(3): 212-215.

Full text of this article.

In the past decade, extracorporeal membrane oxygenation (ECMO) has emerged as an innovative therapy for influenza-associated acute respiratory distress syndrome (ARDS). Despite its promising results, the ideal timing of ECMO initiation for these patients remains unclear. Retrospective analysis of a single institution experience with venovenous ECMO for influenza-induced ARDS was performed. Twenty-one patients were identified and categorized into early (0-2 days), standard (3-6 days), or late (more than 7 days) cannulation cohorts. Patients cannulated within 48 hours of admission had 80% survival rate at 90 days. Comparatively, the standard and late cannulation cohorts had an observed 90-day survival rate of 60 and 16.7%, respectively.

Steimer, D. A., O. Hernandez, D. P. Mason and G. S. Schwartz (2018). “Timing of ECMO Initiation Impacts Survival in Influenza-Associated ARDS.” Thorac Cardiovasc Surg. May 1. [Epub ahead of print].

Full text of this article.

In the past decade, extracorporeal membrane oxygenation (ECMO) has emerged as an innovative therapy for influenza-associated acute respiratory distress syndrome (ARDS). Despite its promising results, the ideal timing of ECMO initiation for these patients remains unclear. Retrospective analysis of a single institution experience with venovenous ECMO for influenza-induced ARDS was performed. Twenty-one patients were identified and categorized into early (0-2 days), standard (3-6 days), or late (more than 7 days) cannulation cohorts. Patients cannulated within 48 hours of admission had 80% survival rate at 90 days. Comparatively, the standard and late cannulation cohorts had an observed 90-day survival rate of 60 and 16.7%, respectively.

Podgaetz, E., G. S. Schwartz and D. P. Mason (2017). “Minimally invasive posterior basilar segmentectomy by a posterior approach: Should we start flipping?” J Thorac Cardiovasc Surg 154(4): 1440-1441.

Full text of this article.

Multiple studies have demonstrated that sublobar resection is an acceptable treatment modality for small peripheral tumors without suggestive lymphadenopathy. 1 Although wedge resection can be achieved thoracoscopically for peripheral lesions, lesions located deep in the lung parenchyma often require a segmentectomy or lobectomy to be certain to fully encompass the tumor. Segmentectomies are far less common than lobectomy and are significantly more technically demanding, even when performed via thoracotomy.